3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
8
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Multiple Myeloma
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphoid
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Blast Crisis
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Precancerous Conditions
2
Interventions
Gemcitabine
33
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
12
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Nivolumab
9
Cystoscopy
9
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
Radiotherapy
6
Immunoglobulin G
6
Docetaxel
6
Disulfides
6
atezolizumab
5
Transurethral Resection of Bladder
5
Mitozytrex
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Standard of Care
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Peripheral Blood Stem Cell Transplantation
×
90 days
×
Clear all
No trials found.